CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
and carboplatin in locally advanced unresectable or metastatic triple-negative breast cancer.The main questions i...
Phase 2
Charlotte, North Carolina, United States
doxorubicin and cyclophosphamide (AC) or epirubicin and cyclophosphamide (EC). Usually, after neoadjuvant therapy and surgery for triple ne ...
Phase 3
Charlotte, North Carolina, United States and 216 other locations
for patients with previously untreated, locally advanced, unresectable or metastatic (Stage IV) programmed death-ligand 1 (PD-L1)-positive triple...
Phase 2
Charlotte, North Carolina, United States and 39 other locations
This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...
Phase 3
Charlotte, North Carolina, United States and 226 other locations
previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...
Phase 3
Charlotte, North Carolina, United States and 516 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Charlotte, North Carolina, United States and 275 other locations
(ABBV-181) and/or chemotherapy in participants with selected solid tumors. This study consists of 2 main parts, a dose-escalation phase and ...
Phase 1
Huntersville, North Carolina, United States of America and 25 other locations
Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-Small Cell Lung Cancer (NSCLC) ...
Phase 1
Huntersville, North Carolina, United States of America and 28 other locations
1/2 study to determine the safety, tolerability, and efficacy of APL-5125 for the treatment of selected locally advanced or metastatic solid tumors...
Phase 1, Phase 2
Huntersville, North Carolina, United States of America and 8 other locations
A phase 1a/1b, multicenter, open-label, dose escalation/expansion, multiple-dose study to evaluate the safety and activity of DR-0202 in patients wit...
Phase 1
Huntersville, North Carolina, United States and 9 other locations
Clinical trials
Research sites
Resources
Legal